COVID-19 Boosters

As you may be aware, the U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna and Pfizer BioNTech COVID-19 vaccines to authorize bivalent formulations for use as a single booster dose at least two months following primary or booster vaccination. Individuals aged 12 and older should only be offered the updated (bivalent) mRNA (Moderna or Pfizer-BioNTech) booster.

Our COVID-19 Updates for Providers page has been updated to reflect this change. For additional information, refer to the FDA News Release and the Center for Disease Control and Prevention (CDC) for up to date information regarding COVID-19 vaccinations, including primary series doses and boosters.